‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

View newsletter on web site HERE

14‑DAY TRIAL    FORMULATIONS    MY ACCOUNT 
Compounding This Week Newsletter from www.CompoundingToday.com
Brought to you by IJPC
Our Compounding Knowledge, Your Peace of Mind
March 29, 2024  |  Volume 21  |  Issue 3
Advertising
IJPC Mar/Apr 2024 Issue

The latest editiion of IJPC is now online! Get a free digital sample, search 25 years of content, and subscribe today to IJPC - The only journal solely dedicated to the art and science of pharmaceutical compounding!

FEATURE ARTICLES

IJPC Mar/Apr 2024, page 94 Magic Mouthwashes- A Literature Review and Discussion of Common Compositions
Linda F. McElhiney, PharmD, RPh, FIACP, FASHP


Compounding magic mouthwash preparations can be a challenge. Although the actual preparation of the mouthwash is not difficult, there is very little published information about these preparations and much of the available data is very dated. Compounding pharmacists need to utilize their compounding resources and drug knowledge to help practitioners develop these formulations to meet the specific needs of their patients. This article discusses some of the more common ingredients used in mouthwash preparations and reviews the minimal data that is available on this topic.

IJPC Mar/Apr 2024, page 100 Compounded Pain Formulations: What is the Evidence
Scott Asbill, PhD, Sarah M. Sweitzer, PhD, Shuler Spigener, BSc Alfonso Romero-Sandoval, MD, PhD


Provides an overview of chronic pain as a disease, the mechanisms of chronic pain, current treatment approaches to chronic pain, and a discussion of the drugs that are typically compounded into topical formulations and studied in clinical trials.

IJPC Mar/Apr 2024, page 111 Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review
Sarah M. Beshay, PharmD, Gerard Rivera, PharmD, Jan Balthasar, PharmD, Naomi Florea, PharmD


This review is aimed towards identifying the literature regarding clinical and therapeutic value of the commonly used ingredients in pain management compounds: lidocaine, tetracaine, ketoprofen, ketamine, and gabapentin.

IJPC Mar/Apr 2024 page 118 Safe Use of Topical Local Anesthetic Medications for Pain Management
Mikhail G. Epshteyn, PharmD, Steven M. Pepin, PharmD


Topical local anesthetics can be used safely to treat a variety of conditions in hospitalized and ambulatory patients. Following the above safety precautions will ensure that patients receive the maximum benefit from topical anesthetic with minimized risk of undesirable and potentially harmful side effects.

Table of Contents
Complete contents, abstracts, page previews, and subscriber downloads are available on the IJPC Issue Page.

APPLIED COMPOUNDING

Sterile Basics: Sterile Filtration

PEER REVIEWED

FORMULATIVE STUDY: Hydrophilic Ready-to-use Vehicles and Compounded Topical Medications

FORMULATIVE STUDY: Lipophilic Ready-to-use Vehicles and Compounded Topical Medications

STABILITY STUDY: Physical-chemical Stability of the Extemporaneous Paracetamol Oral Suspension in Puccini Base

STABILITY STUDY: Stability Evaluation of Bracketed Diclofenac Sodium USP in VersaProâ„¢ Cream Base, VersaProâ„¢ Gel Base and PLO Gel Medifloâ„¢ 30 Compound Kit

COMPATIBILITY STUDY: Compatibility of Caffeine Clobetasol Propionate Dutasteride Nicotinamide and Progesterone in TrichoFoamâ„¢, a Natural Vehicle for Hair Foams

CLINICAL STUDY: Clinical Safety Profile of TrichoConceptâ„¢, a Line of Cosmetic Vehicles for Personalized Treatment of Alopecia

FORMULATIONS

Amitriptyline 4%, Dextromethorphan Hydrobromide 20%, and Tramadol Hydrochloride 5% in Pluronic Lecithin Organogel

Amitriptyline Hydrochloride 2%, Carbamazepine 2%, Gabapentin 10%, and Ketoprofen 2% Transdermal Gel

Analgesic Compound Lotion, Clear

Benzocaine 20%, Lidocaine 6%, and Tetracaine 4% in Lipoderm

Diclofenac Sodium 1% Soft-patch Gel

Ketamine Hydrochloride 5%, Gabapentin 10%, Clonidine Hydrochloride 0.2%, and Baclofen 2% in Lipoderm

Ketoprofen 10%, Baclofen 2%, Cyclobenzaprine Hydrochloride 2%, Lidocaine 2% in Lipopen Ultra Cream Base

Rectal Rockets: Lidocaine 3%, Hydrocortisone 2%

DEPARTMENTS

EDITORIAL/PRESCRIPTION: Compounding for Pain Management Patients

CALCULATIONS: Isotonic Solution Potency Range and Solubility Calculations

ERRATA, ADDENDA, and SUPPLEMENTAL: Addendum to Compounded Beta-blocker Nasal Spray for Treatment of Acute Migraine A New Therapeutic Modality
Advertising

Join the CNL!

IJPC would like to invite all compounding pharmacists and technicians to join the Compounders' Network List (CNL) - an e-mail-based resource for sharing compounding information with your peers.

Go to the following website for more information and to join.

https://ijpc.com/cnl

From Out of the Past

The Happy Golfer
Finds with Glee
The Shave
That Suites Him
To a Tee
     Burma-Shave

Thanks to our advertisers in this featured Mar/Apr 2024 issue. Please support them when possible.

Advertising Analytical Research Laboratories CompoundingToday.com Eagle Analytical Medi-Dose/EPS Medisca Pharmacy Compounding Accreditation Board Professional Compounding Centers of America Pharma Source Direct RXinsider Team Technologies ZRT Laboratory
Manage my Email:
Subscribe / Remove from List
Comments or Questions:
info@compounding​today.com
Copyright 2024
IJPC Inc., 122 N Bryant Ave, Edmond OK 73034
Reprints & Permissions: Reprints@ijpc.com